Susan Hasty, Publisher
Table of Contents . . . March 27th, 1995Non-Subscriber - Summaries Only
Conference Coverage - CEA-Vaccinia Cancer Vaccine Trial: Two Strikes, But Still At Bat
Conference Coverage - Cancer Vaccine Research Now a Priority
Conference Coverage - Naked CEA-DNA Vaccine Protects Mice Against Tumor
Chemotherapy/Drug Interactions - Cisplatin Resistant Ovarian Cancer Which Responds to Taxol Induces Peripheral Neurotoxicity
Disease Associations - Possible Association Between Certain HLA Class II Haplotypes and Cervical Cancer
Genetics/Smoking Issues - Molecular Proof Linking Smoking to Cancer Found
Helicobacter Pylori - Possible Ulcer Vaccine Developed
Industry News/Joint Venture - Anti-CD20 Monoclonal Antibody Collaboration for B-Cell Lymphomas
International/United Kingdom - Court Upholds Refusal To Treat Child in Landmark Case
Transplantation - Dual Process May Improve Overall Success
Viral Vectors - Results Encouraging in Brain Cancer Gene Therapy Trials
Anitisense Therapy - "Regulation of Malignant B-1 Cells by IL-10 Antisense Oligonucleotides."
Immunology - Gene Therapy - "Gene Therapy of Human Melanoma by Particle Bombardment."
Astrocytomas - Genetic Lesions of the p53 Gene - "Single Cell Monitoring of Growth Arrest and Morphological Changes Induced by Transfer of Wild-Type p53 Alleles to Glioblastoma Cells."
Diagnostics - Expression of the CD30 Molecule - "CD30 Antigen in Embryonal Carcinoma and Embryogenesis and Release of the Soluble Molecule."
Human Papillomavirus - Design of Subunit Vaccines - "Peptide Engineering Allows Cytotoxic T-Cell Vaccination Against Human Papillomavirus Tumour Antigen, E6."
Melanoma - Interferon Responsiveness - "Resistance of Melanoma Cell Lines to Interferons Correlates with Reduction of IFN-Induced Tyrosine Phosphorylation - Induction of the Anti-Viral State by IFN is Prevented by Tyrosine Kinase Inhibitors."
Ovarian Cancer - Activation of c-K-ras Oncogene - "Detection of c-K-ras Point Mutation in Ovarian Cancer."
Ovarian Cancer - Therapy - "Platinum Plus Cyclophosphamide Plus Radiotherapy is Superior to Platinum Alone in 'High-Risk' Epithelial Ovarian Cancer (Residual Negative and Either Stage I or II, Grade 3, or S
Therapy - Combined Hyperthermia and Chemotherapy - "A New Approach using Local Combined Microwave Hyperthermia and Chemotherapy in Superficial Transitional Bladder Carcinoma Treatment."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.